Ip Share Discussion Threads

[bamboo2] 03/6/2020 19:20

rambutan2, agree about forced selling.

That's the whole reason the share price is where it is!
Two very significant shareholders have sold well over 35% of the co in the past 12 months. Forced sellers.

The good news is that there is still demand for the shares, and the discount to nav is no longer a mile wide. Other benefits to this situation are that we can buy cheaply, and management have had to become more active to start realising cash from the constituents that have a market. This is precisely what the co needs to be doing, to provide the capital to fund the investments of the future.

[rambutan2] 03/6/2020 14:52

Wetpantz, it's down to the huge redemptions from the Henley funds which hold IPO. They've been selling heavily right across the board. They don't have a choice. If investors sell, Invesco have to pay them cash. And these are daily dealing funds remember.

[wetpantz] 03/6/2020 11:20

Invesco seemed to have slowed the pace of selling down IPO. Can understand why they're desperate to dump anything touched by Woodford but have missed out on 20% gains in last few weeks. Illustrates how asset managers pay far more attention to marketing than monitoring what's going on in their portfolio companies.

[bamboo2] 02/6/2020 16:57

Would imagine we are due another holdings rns from Invesco on the good volume today.

Chart suggests a potential turn today could be confirmed as a low turn, assuming a positive eod close tomorrow.

[wetpantz] 01/6/2020 13:12

House broker Berenberg increased IPO price target to 100 today. Jeffries (not house broker) increased TP to 80p last week.

[wetpantz] 29/5/2020 19:29

UK biotech is finally coming of age, given weak GBP and oodles of dry powder being mustered in the US, I'd expect buyers to coming knocking on IPO's door soon. Let's hope the management have learn some lessons in securing timely profitable exits for future investments. Some comment on future deal pipeline would be welcome too.

[bamboo2] 29/5/2020 19:12

Topped up today as my charts showing a potential turn early next week.

I think the co should hold a large pot of cash. The days of easy money from Woodford etc are over.

We should be focusing on the transition of new tech from Universities, sharing risk with other providers of capital. Once a business is established, IP Group should cash out, to provide funds for the next generation.

[p1nkfish] 29/5/2020 10:16

Forget cash back outside of some potential tender offerfor a %.

I agree with Pierre.

The picture is much bigger than a few quick buck merchants. If not happy, sell. Simple enough.

[pierre oreilly] 29/5/2020 10:13

Btw, I'm not a trader continually buying and selling - my approach is to build a decent investments in a few companies and hold for years and years. That has served me well. I'm not here to hopefully quickly take out cash others have built up over the years - I want some sort of reliable annual gain for the long term. Everything added up here for me six months ago (all the numbers looked great, and still do), only I didn't consider one factor i now realise is very important.

[brucie5] 29/5/2020 09:11

A treasure trove of technologies, most of them barely comprehensible. Reminds me somewhat of BTG back in the day. I wonder if wouldn't make sense for some venture capitalists to take it over at current discount and then start selling off the most obviously discounted stories. Not what I would like, but value will out. It's really the management's job to ensure that.

[bamboo2] 28/5/2020 23:06

Newsletter May 2020

[wetpantz] 28/5/2020 19:24

Maybe some share buybacks are in order, given the discount to NAV. Reinvestment into early stage companies is fine but track record of timely profitable exits is poor, maybe the Parkwalk team will do better. Given that seed funding only pays off very rarely, its borderline negligent of them to sell off bits of Nanopore prematurely. Softbank would be nothing if it had sold off Alibaba pre-IPO.

[p1nkfish] 28/5/2020 16:30

Nonsense.

As of end 02/05/2020 46% was with 3%+ holders and another 10% with institutions < 3% down to 1.68%. Some others <1%.

A tender offer more likely if anything at all.

Dyor, be careful believing BS on PBBs.
They should recycle proceeds.

[wetpantz] 28/5/2020 15:31

@dexdringle. Management had already cut costs at last annual report. Now that Woodford and chums now longer hold the lions share of stock, IPO management will be nervously looking over their shoulder. 85% is held by institutions and 10% hedge funds they will want to see some special dividends and even lower admin costs.

[p1nkfish] 28/5/2020 15:30

They need to invest it. The UK need growth capital into more new industries at the leading edge. No excuse for paying any out yet imho.

[dexdringle] 28/5/2020 15:05

My concern remains that the management here have demonstrated poor judgement. If Oxford Nanopore floats, and IPO get a large wedge of cash, we need to make sure they pay it out to shareholders asap before they waste it / burn it away in costs. The management have a great deal of credibility building to do still....

[brucie5] 28/5/2020 13:58

I think there's a fair chance that 40 was the secular bottom and that 60 is the new point of consolidation. Could well be wrong. But I sense there will be a further good buying opportunity on confirmation/testing of the level. Followed by take off. Yes, I keep an eye on Oxford Nanopore; I think it's going to be huge, and already appears to be world leading tech at the sharp (if unsung) end of international management of COVID. Going forwards, there's just no way governments are going to allowed to take their eyes off the ball of future pandemic risk, so this tech may become non-dispensible̷0; if it isn't already. An IPO, when it comes, will enable to the company to present the opportunity much more clearly. At the moment it seems to be largely left to us to join the dots.

[benchmark] 28/5/2020 11:51

I anticipate a further announcement from Ox Nanopore within a few weeks concerning a Covid RNA sequencing analysis procedure commissioned by the UK government, i.e. different from the LamPORE assay

[wetpantz] 28/5/2020 11:19

Oxford Nanopore are keeping pretty quiet about their recent sales growth, their products seem to be flying off the shelves with some of their machines on 8-12 week lead time. I suspect recent fundraise was to ramp up production capacity faster than originally planned. Management are wary of premature takeover approaches so maybe keeping a low profile to avoid unwanted attention. The 2 other main players in DNA sequencing Illumina and Pacbio both saw their 2020 Q1 fall year on year so could be a sign they are losing market share, now that Oxf Nano has nailed the accuracy issues in its product.

[brucie5] 28/5/2020 11:05

Bought back in... just under 64p. Let's see.
I'm not expecting fireworks, but there's a bit too much of that on the market already.

[bamboo2] 26/5/2020 20:22

Woodford and Invesco held very significant amounts of both IP Group and its constituents. The redemption's that these two holders have experienced have been well documented, and subsequent sales have seriously affected many of the co's sp's.

This fact alone has led to the changes in management we are now seeing. It will take some time, but soon enough we should start seeing IP Group start show a positive bottom line. Then we may see dividends.

I find it hard to understand why holders, who must be aware of the history, can't seem to accept that changes had to be made, and that this will take a while to show fruit.

[wetpantz] 26/5/2020 19:43

They chose some decent investments, sat on them for a decade or more, then sell out or dilute just as the values are rocketing. What planet do these muppet management come from? CEO has a decent size holding of IPO shares so must enjoy impoverishing himself. I wonder if these shares are being sold to related parties on the cheap.

[bamboo2] 26/5/2020 16:41

wetp, afaik, they are all out of avct. These were sold into the initial rise.

Management announced there would be a removal some of the biotec holdings below 25% in the last results. Looks like very unfortunate timing in hindsight.